Providing healthcare to millions of people requires a hugely complex system of hospitals, clinics, ambulances, research centers, suppliers, and governments-and that system needs re-engineering.
Although mending broken bones or prescribing medication may seem like simple tasks at a hospital, providing healthcare to millions of people is anything but. It requires a hugely complex system of hospitals, clinics, ambulances, research centers, suppliers, and governments—and according to Professor Timothy Chan, that system needs re-engineering.
Mr Chan is the new director of U of T Engineering’s Centre for Healthcare Engineering (CHE) (formerly the Centre for Research in Healthcare Engineering). The collaborative hub brings a highly interdisciplinary, systems engineering approach to drastically improve how healthcare works.
“Healthcare systems are a lot like giant factories—they involve a large number of people and processes all working together in different stages to meet one goal,” said Mr Chan. “At the CHE, we pioneer research that optimizes many of those stages, making healthcare delivery more efficient, less costly and quicker.”
Read more: http://bit.ly/1uXdGaE
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More